Markets:

Overview

News

Currencies

International

Treasuries

bioAffinity Technologies, Inc. - Common Stock (NQ:BIAF)

4.643 +0.672 (+16.94%)

Streaming Delayed Price Updated: 3:40 PM EDT, Mar 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about bioAffinity Technologies, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

July 12, 2024

Via ACCESSWIRE

bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung

July 09, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

July 05, 2024

Via ACCESSWIRE

bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests

June 12, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q1 2024 ↗

May 15, 2024

bioAffinity Technologies just reported results for the first quarter of 2024.

Via InvestorPlace

bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes

May 15, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies News Update

May 02, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth

April 24, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening

April 09, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 05, 2024

Via Benzinga

BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q4 2023 ↗

April 01, 2024

bioAffinity Technologies just reported results for the fourth quarter of 2023.

Via InvestorPlace

bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results

April 01, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 11, 2024

Via Benzinga

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 11, 2024

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart...

Via Benzinga

bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

March 08, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

Nasdaq Gains 100 Points; Campbell Soup Earnings Top Views ↗

March 06, 2024

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Wednesday. The Dow traded up 0.20% to 38,662.69 while the NASDAQ rose 0.64% to 16,041.08. The...

Via Benzinga

Topics Stocks

Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 06, 2024

Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 06, 2024

Via Benzinga

Why BioAffinity Technologies (BIAF) Shares Are Down 50% ↗

March 06, 2024

BioAffinity Technologies shares are trading lower by 50.7% during Wednesday's session. The company announced a securities purchase agreement with institutional investors.

Via Benzinga

bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

March 06, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung

March 05, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 05, 2024

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.

Via Benzinga

bioAffinity Technologies News Update

February 21, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice

February 06, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies In The News

January 30, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer

January 23, 2024

From bioAffinity Technologies

Via Business Wire

bioAffinity Technologies In the News

January 08, 2024

From bioAffinity Technologies

Via Business Wire

bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

January 05, 2024

Via ACCESSWIRE

Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 19, 2023

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy...

Via Benzinga

bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors

December 05, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Subscribe
Contact Us
About Press Telegram
Marketplace
Advertising Solutions
Reader Rewards
Subscribe Now

Terms of Use
Cookie Policy
Cookie Preferences
California Notice at Collection
Notice of Financial Incentive
Do Not Sell/Share My Personal Information
Arbitration
Powered by WordPress.com VIP

Copyright 2026 Press Telegram. All rights reserved. The use of any content on this website for the purpose of training artificial intelligence systems, algorithms, machine learning models, text and data mining, or similar use is strictly prohibited without explicit written consent.